Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China flag China · Delayed Price · Currency is CNY
32.16
+0.31 (0.97%)
Feb 4, 2026, 3:00 PM CST

SHA:603882 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
14,75512,64429,33136,53051,85258,870
Market Cap Growth
21.00%-56.89%-19.71%-29.55%-11.92%151.01%
Enterprise Value
13,22411,59428,04234,61050,76558,143
Last Close Price
31.8526.9359.4472.47101.64116.66
PE Ratio
--45.5913.2623.3638.99
Forward PE
29.6320.3231.6818.2927.1555.22
PS Ratio
2.421.763.442.364.347.14
PB Ratio
2.121.693.434.127.9515.19
P/TBV Ratio
2.231.783.594.328.3316.19
P/FCF Ratio
16.8627.4956.8432.9945.6660.54
P/OCF Ratio
11.6513.9523.8318.7524.8338.65
PEG Ratio
-1.35-4.576.79-
EV/Sales Ratio
2.161.613.282.244.257.05
EV/EBITDA Ratio
84.3844.9632.369.4116.6128.14
EV/EBIT Ratio
--67.5810.6018.6432.57
EV/FCF Ratio
15.1125.2154.3431.2644.7159.79
Debt / Equity Ratio
0.110.100.070.060.100.11
Debt / EBITDA Ratio
5.022.040.590.150.200.20
Debt / FCF Ratio
0.901.631.120.510.550.43
Asset Turnover
0.590.650.671.261.371.49
Inventory Turnover
20.0921.5316.6023.4621.5921.46
Quick Ratio
3.003.112.952.222.021.93
Current Ratio
3.143.283.072.332.132.06
Return on Equity (ROE)
-7.85%-5.18%7.31%36.95%45.46%50.74%
Return on Assets (ROA)
-2.30%-1.02%2.02%16.57%19.58%20.22%
Return on Invested Capital (ROIC)
-7.03%-2.90%5.42%50.84%65.56%66.82%
Return on Capital Employed (ROCE)
-5.00%-2.20%4.60%35.10%38.80%41.20%
Earnings Yield
-3.76%-3.02%2.19%7.54%4.28%2.56%
FCF Yield
5.93%3.64%1.76%3.03%2.19%1.65%
Dividend Yield
2.85%3.27%1.48%2.46%1.26%0.28%
Payout Ratio
--130.46%22.13%7.66%6.09%
Buyback Yield / Dilution
0.56%0.28%0.15%-0.13%-1.00%-0.98%
Total Shareholder Return
3.41%3.55%1.63%2.33%0.26%-0.70%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.